Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,285,563
+$1,199,735 QoQ
Shares Held
3,573
+6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,834
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ironwood Investment Counsel, LLC holds $31,349,950 across 7 Drug Manufacturers - General names. LLY ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,795 | $16,202,016 | |
| 2 | AMGN |
Amgen Inc
|
20,809 | $7,535,355 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
3,573 | $4,285,563 | |
| 4 | ABBV |
AbbVie Inc.
|
9,119 | $2,294,705 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,171 | $400,624 | |
| 6 | PFE |
Pfizer Inc
|
15,465 | $372,397 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,500 | $259,290 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,285,563 | 3,573 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,085,828 | 3,355 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,622,746 | 3,371 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,637,691 | 3,457 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,761,095 | 3,542 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,944,369 | 3,565 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,684,244 | 3,477 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,075,983 | 3,472 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,150,722 | 3,480 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,666,846 | 3,428 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,997,666 | 3,427 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $34,293 | 3,255 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,522,778 | 3,247 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,128,478 | 3,286 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,292,878 | 3,534 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,144,335 | 3,539 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,098,491 | 3,388 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $999,717 | 3,491 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $985,000 | 3,566 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $823,924 | 3,566 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $772,564 | 3,366 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $647,518 | 3,466 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $608,668 | 3,605 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $358,652 | 2,423 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $392,061 | 2,388 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $327,656 | 2,362 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||